The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate
- Authors
- Koh, Seong-Ho; Baik, Wonki; Noh, Min Young; Cho, Goang Won; Kim, Hyun Young; Kim, Kyung Suk; Kim, Seung Hyun
- Issue Date
- Jan-2012
- Publisher
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- Keywords
- Amyotrophic lateral sclerosis; Prognostic factors; Neurotrophic factors; Mesenchymal stromal cells
- Citation
- EXPERIMENTAL NEUROLOGY, v.233, no.1, pp.472 - 480
- Indexed
- SCIE
SCOPUS
- Journal Title
- EXPERIMENTAL NEUROLOGY
- Volume
- 233
- Number
- 1
- Start Page
- 472
- End Page
- 480
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/166583
- DOI
- 10.1016/j.expneurol.2011.11.021
- ISSN
- 0014-4886
- Abstract
- Amyotrophic lateral sclerosis (ALS) is caused by motor neuron death. The relationship between the prognosis of ALS patients and the function of their bone marrow mesenchymal stromal cells (BM-MSCs) is unclear. We designed this study to assess the correlation between the progression rate of the ALS Functional Rating Scale-revised version (Delta FS), which is reported to predict prognosis, and the pluripotency and trophic factor secreting capacity of ALS patients' BM-MSCs. We evaluated Delta FS in 23 ALS patients and isolated BM-MSCs from those patients and five healthy people. Levels of Nanog, Oct-4, and Nestin mRNA were examined to evaluate pluripotency, and levels of BDNF, ECGF1, bFGF-2, HGF, IGF-1, PGF, TGF-1 beta, SDF-1 alpha, GDNF, VEGF, and ANG mRNA were examined to assess trophic factor secreting capacity. In addition, we measured the protein levels of Nanog, Oct-4, Nestin, SDF-1 alpha, ANG, bFGF-2, VEGF, IGF-1, GDNF, and BDNF. mRNA levels of Nanog, Oct-4, ECGF1, bFGF-2, HGF, IGF-1, PGF, TGF-1 beta, SDF-1 alpha, GDNF. VEGF, and ANG were negatively correlations with Delta FS. However, those of Nestin and BDNF were not significantly correlated with Delta FS. Similarly, Nanog, Oct-4, SDF-1 alpha, ANG, bFGF-2, VEGF, IGF-1, and GDNF protein levels had a significant negative correlation with Delta FS. Results indicate that the pluripotency and trophic factor secreting capacity of the BM-MSCs of ALS patients are reduced in proportion to a poorer prognosis. We therefore suggest that healthy allogeneic BM-MSCs might be a better option for cell therapy in ALS patients.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 신경과학교실 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.